Your shopping cart is currently empty

TD-198946, a potent chondrogenic agent, is a thienoindazole derivative.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $72 | In Stock | In Stock | |
| 5 mg | $147 | In Stock | In Stock | |
| 10 mg | $238 | In Stock | In Stock | |
| 25 mg | $429 | In Stock | In Stock | |
| 50 mg | $568 | In Stock | In Stock | |
| 100 mg | $789 | Inquiry | Inquiry | |
| 1 mL x 10 mM (in DMSO) | $156 | In Stock | In Stock |
| Description | TD-198946, a potent chondrogenic agent, is a thienoindazole derivative. |
| In vitro | In cell and metatarsal organ cultures, TD-198946 markedly induces chondrogenic differentiation without promoting hypertrophy. In ATDC5 cells, TD-198946 induces stronger?Col2a1?promoter activity than insulin. In C3H10T1/2 cells, ATDC5 cells and primary mouse chondrocytes, TD-198946 dose-dependently stimulates endogenous expression of the chondrocyte markers?Acan?and?Col2a1 (maximum effects: 1-10 μM). |
| In vivo | TD-198946 can prevent and repair degeneration of the articular cartilage by administered directly into the joint space. TD-198946 regulates Runx1 expression, which is downregulated in both mouse and human OA cartilage compared with normal tissue. TD-198946 may prevent the progression of osteoarthritis by acting on the remaining chondrocytes rather than repairing damaged cartilage. Cartilaginous cell-sheets are generated by culturing human mesenchymal stem cells and canine and mouse costal chondrocytes with TD-198946 on temperature-responsive dishes. |
| Animal Research | For intra-articular injection, TD-198946 is dissolved at 100 nM in a solution of 45% 2-hydropropyl-b-cyclodextrin in saline.Mouse: Each of the prevention and repair models had two groups: (1) TD-198946-treated animals and (2) saline-treated animals. In all the mice tested the left knee joints underwent the operation and the right knee joints are sham-operated. Mice are re-anesthetized and given a 10 μL intra-articular injection of TD-198946 or saline immediately after surgery (prevention model) or 4 weeks following surgery (repair model) every 5 days for 8 or 4 weeks, respectively. |
| Synonyms | TD198946, TD 198946 |
| Molecular Weight | 482.55 |
| Formula | C27H22N4O3S |
| Cas No. | 364762-86-7 |
| Smiles | Cn1ncc2CCc3c(sc(Oc4ccc(OCc5ccc6ccccc6n5)cc4)c3-c12)C(N)=O |
| Relative Density. | 1.43 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (103.62 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.